- ISO 17025 lab-tested
- 99%+ purity
- Research use only
KLOW 80mg - GHK-CU 50mg, TB-500 10mg, BPC-157 10mg, KPV 10mg
-
Processed as soon as payment clears
Packed and dispatched without delay.
-
Free shipping over €99.00 to most EU countries
-
Shipment protection included
Lost or damaged in transit? We send a replacement.
-
Discreet packaging
Plain parcel, no product names on the outside.
-
We accept
Secure checkout
- SEPA bank transfer
Independent lab results
Tested before it reaches your bench
Every batch is analysed by an independent, ISO 17025-accredited laboratory before release. The report shown here belongs to the batch now shipping, so what you read is what you receive.
Analiza Białek sp. z o.o.
ISO/IEC 17025 accredited
HPLC purity
99%
Release minimum: 99%
- Lot
- KLOW/012026
- Tested
- March 12, 2026
- Measured
- 10.65 mg
- Report no.
- 3NL934BG
- Batch-specific
- Independent lab
Quality control results
2 passed · 5 reported-
Purity
Reversed-phase HPLC
99% Pass -
Net peptide content
HPLC quantitation · BPC-157
10.65 mg Reported -
Net peptide content
HPLC quantitation · TB-500
10.11 mg Reported -
Net peptide content
HPLC quantitation · GHK-Cu
51.87 mg Reported -
Net peptide content
HPLC quantitation · KPV
10.22 mg Reported -
Endotoxin
Endotoxin assay
<0.5EU/mg Reported -
Sterility
Microbial culture · TYMC, TAMC, Escherichia Coli, Salmonella Spp.
Within limits Pass
Tests in our panel
- Visual inspection · Colour, form and integrity of the lyophilised powder and the vial seal, checked against the specification.
- LC-MS · Confirms the molecular mass matches the expected structure of the compound.
- Impurity profile · Checks for residues from synthesis and handling that should not be present.
- Elemental analysis · Screens for toxic metals that can enter through raw materials or equipment.
All published batches
Every lot of this product we have released, each with its own certificate. Newest first.
KLOW 80mg - GHK-CU 50mg, TB-500 10mg, BPC-157 10mg, KPV 10mg
LatestLOT KLOW/012026
99%
HPLC purity
- Measured content · BPC-157
- 10.65 mg
- Measured content · TB-500
- 10.11 mg
- Measured content · GHK-Cu
- 51.87 mg
- Measured content · KPV
- 10.22 mg
- Endotoxin
- <0.5EU/mg
- Sterility
- Within limits
- Tested on
- March 12, 2026
10 assays by Analiza Białek sp. z o.o.
Open certificate
About this compound
KLOW Peptide 80 mg – Advanced Synergistic Regeneration Complex (GHK-Cu + TB-500 + BPC-157 + KPV)
- Composition: GHK-Cu 50 mg | TB-500 10mg | BPC-157 10mg | KPV 10 mg
- Category: Peptide Research Compound
- Form: Vial containing lyophilized powder
What is KLOW Peptide?
KLOW Peptide is an advanced multi-component regenerative peptide complex developed for research applications in tissue repair, skin health, inflammation control, and cellular regeneration.
This upgraded formulation combines four extensively studied peptides: GHK-Cu , TB-500 , BPC-157 , and KPV . Each peptide contributes a distinct biological mechanism, creating a highly synergistic profile suitable for comprehensive regeneration and rejuvenation studies.
GLOW Peptide is particularly relevant for experimental models focused on collagen remodeling, wound healing, inflammatory modulation, and epithelial barrier recovery.
Explore the enhanced synergistic potential of this next-generation peptide complex.
Key Research Findings
GHK-Cu (50 mg): A copper-binding peptide studied for its role in collagen and elastin synthesis, angiogenesis, and improvement of skin structure and elasticity through copper-mediated tissue repair pathways.
TB-500 (10 mg): A synthetic fragment of thymosin beta-4 known to promote cell migration, cytoskeletal organization, and wound healing, supporting soft tissue regeneration and recovery.
BPC-157 (10 mg): A stable pentadecapeptide researched for its gastroprotective, neuroprotective, and angiogenic properties, with particular relevance to tendon, ligament, and vascular healing.
KPV (10 mg): A tripeptide fragment of alpha-MSH investigated for its potent anti-inflammatory and immunomodulatory effects, including regulation of cytokine activity and support of epithelial integrity.
Synergistic Effect: The combined action of these four peptides may enhance fibroblast activity, reduce oxidative stress, suppress inflammatory signaling, and accelerate cellular regeneration more effectively than individual compounds alone.
Storage Instructions
- Store unopened vials at 2–8 °C (36–46 °F)
- Protect from light and moisture
- Do not freeze
- Avoid repeated temperature fluctuations
Why Choose KLOW Peptide?
KLOW Peptide combines the collagen-stimulating effects of GHK-Cu , the regenerative support of TB-500 , the protective healing properties of BPC-157 , and the anti-inflammatory modulation of KPV in one balanced, synergistic formulation.
This advanced combination makes GLOW Peptide a preferred research compound for studies involving:
- Skin rejuvenation
- Wound healing
- Soft tissue and vascular repair
- Inflammation control and epithelial recovery
- Cellular regeneration and tissue remodeling
Order KLOW Peptide 80 mg and explore the next level of peptide-based regenerative research.
Research notice
For laboratory research use only. This product is not a medicinal product or a food. It is not intended for human or veterinary use, or for any diagnostic or therapeutic purpose.
The buyer is responsible for receiving, storing, handling and disposing of this material safely and lawfully, in line with the rules of their country and institution. We sell only to adults aged 18 or over who are qualified to work with research materials.
Descriptions on this page summarise published research for educational purposes. They are not medical advice and make no claim about safety or effects in humans.
